TO START A CELL LICENSING REQUEST – PLEASE FILL OUT REQUEST FORM

Next generation bioanalytical solutions

Our licensing process:

Neukopanel® Request Form

for Proprietary Neukoplast® NK-92 Cells

Please complete form to initiate licensing process

Fill out my online form.

Taking you beyond the Brink of binding™
with our Killer Assays™.

THE NK-92® ASSAY COMPANY

Brink Biologics, Inc. (BBI) is a NantKwest Inc. (NASDAQ: NK) affiliated biotechnology solutions company located in the prestigious Torrey Pines biotechnology science park in San Diego, CA.

KILLER CELLS - KILLER ASSAYS™

Natural Killer cell lines originating from a singular source, established in stable cultures under GLP & cGMP conditions and further modified into multiple panels of lines suitable for a range of laboratory testing applications.

Proprietary NEUKOPANEL® CELL LINES

A standardized panel of CD16 expressing NK-92® cell lines, provides for the first time the means to establish a consistent, robust and reliable assay for assessment of ADCC activity.

ADCC ASSAYS – ROUTINE HASSLE

Brink Biologics, Inc. holds the exclusive non-clinical rights to the NK-92®️ cell line and its CD16 expressing derivatives, all of which are uniquely and ideally suited for antibody-dependent cell-mediated cytotoxicity (ADCC) assays.

ROUTINE ASSAY
TIME CONSUMING AND A LACK OF OPTIONS

NK-92® cells are the only continuously growing human NK cell adapted to mass production
Brink Biologics created the NK-92® master cell bank (MCB).

EXCLUSIVE

NK-92® MCB has been accepted as clinical grade material by regulatory agencies across the world, including the US FDA, EMEA and Canada Health.
RECOGNIZED QUALITY

The sole holder of homogeneously pure NK-92® cell cultures with superb retention of phenotypic characteristics in more than 6 months of continuous culture.
PURE CELL LINE

Five Advantages of Neukopanel® Cell Lines:

For the first time the means to establish a consistent, robust and reliable assay for assessment of true ADCC function.

Cost & Time Savings

True Cytotoxicity

Ease of Use

Robust Assay

Eliminates Phenotypic Variability

  • Cost and time savings over common practice using donor-sourced (PBMC) NK cell isolation, expansion and maintenance in short term cultures
  • Eliminates phenotypic variability of donor-sourced NK cells as Neukopanel cell lines offer clonal consistency, purity and reliability as an assay reagent
  • Ease of use over donor-sourced NK cells and capable of long-term continuous cultures
  • Ability to generate a readout spectrum with the use of our homozygous high and low affinity CD16 expressing lines alongside our negative control line for assay robustness
  • True cytotoxicity rather than cell-binding readouts

RECENT NEWS

Office

3530 John Hopkins Court
San Diego, CA 92121

Hours

8am to 5pm M-F

Call Us

Main: (858) 633-0300
Fax: (858) 380-1999

Email: info@brinkbiologics.com

©2015-2021 Brink Biologics, Inc. All Rights Reserved | HomePrivacy Policy | Legal Notice | Patent Notice

‘Brink Biologics’, ‘Taking You Beyond the Brink of Binding’, ‘Neukopanel’, ‘Killer Assays’ and ‘laNK’ are trademarks or registered trademarks of Brink Biologics, Inc., ‘haNK’, 'Neukoplast', and ‘NK-92’ are registered trademarks of Nantkwest, Inc.
The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.